共 6 条
[1]
Treatment of hospitalized patients with complicated skin and skin structure infections:double-blind, randomized, multicenter study of piperacillintazobactam versus ticarcillin-clavulanate. Tan JS,Wishnow RM,Talan DA,et al. Antimicrobial Agents and Chemotherapy . 1993
[2]
Determinants of the activity of -lactamase inhibitor combinations. Libermore DM. Journal of Antimicrobial Chemotherapy . 1993
[3]
Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. Comerra A,Zinner S,Bock R,et al. Antimicrobial Agents and Chemotherapy . 1995
[4]
Multicenter evaluation of the antimicrobial activity for six broad-spectrum beta-lactams in Veneauela using the E test method. Pfaller MA,Jones RN,Doern GV,et al. Diagnostic Microbiology and Infectious Disease . 1998
[5]
Comparative antimicrobial activity of piperacillin-tazobactam tested against more than 5000 recent clinical isolates from five medical centers. Marshall SA,Aldridge KE,Allen SD,et al. Diagnostic Microbiology and Infectious Disease . 1995
[6]
Comparation of the bactericidal activities of piperacillin-tazobactam, ticarcillinclavulanate, and ampicillin-sulbactam against clinical isolates of Bacteroides fragilis, Enterococus faecalis, Escherichia coli, and Pseudomonas aeruginosa. Klepser ME,Marangos MN,Zhuz,et al. Antimicrobial Agents and Chemotherapy . 1997